Stress-Induced Takotsubo Cardiomyopathy Triggered by Awake Fiberoptic Intubation: A Case Report [PDF]
S. Khandelwal, S. Goyal
openalex +1 more source
Arrhythmias associated with immune checkpoint inhibitor therapy—A clinical perspective
Immune checkpoint inhibitors (ICIs) have transformed cancer therapy but are associated with a growing spectrum of cardiovascular immune‐related adverse events. Among these, arrhythmias represent a rare yet potentially life‐threatening complication. ICI‐induced arrhythmias encompass a wide clinical spectrum, including atrial arrhythmias, conduction ...
Dong Wang +4 more
wiley +1 more source
Volvulus is Stressful: Stress-Induced Cardiomyopathy Secondary to Gastric Volvulus and Paraesophageal Hernia. [PDF]
Jaafar N, Sharma R, Sairam J, Duddu A.
europepmc +1 more source
The Heart of the Issue: A Case Report of Recurrent Reversible Stress-Induced Cardiomyopathy. [PDF]
Platzer P +2 more
europepmc +1 more source
Takotsubo Cardiomyopathy (Stress-Induced Cardiomyopathy): A Narrative Review
Ganchimeg Basan
openalex +1 more source
Abstract Background and Purpose Anthracyclines such as doxorubicin (DOXO) remain a cornerstone of cancer therapy but are associated with a high risk of cardiotoxicity and subsequent heart failure (HF). Impairment of NO/soluble guanylyl cyclase (sGC)/cGMP pathway has been reported in anthracycline‐induced cardiomyopathy.
Olga Gawrys +14 more
wiley +1 more source
Association of Endocrine Conditions With Takotsubo Cardiomyopathy: A Comprehensive Review
Sonali Gupta +5 more
doaj +1 more source
Rapid identification and management of stress-induced cardiomyopathy using POCUS after strangulation: A case report. [PDF]
An J, An J, Lee SE.
europepmc +1 more source
Stress-induced cardiomyopathy (takotsubo syndrome) in a patient with primary hemochromatosis
E.V. Reznik +5 more
openalex +1 more source
Heart failure medication to prevent cancer therapy–related cardiac dysfunction: A narrative review
Advances in oncological therapies have improved cancer survival but also have increased the clinical incidence of cancer therapy–related cardiac dysfunction (CTRCD), a spectrum of conditions ranging from subclinical biomarker or strain abnormalities to progressive heart failure and cardiogenic shock.
Fabian Voß +3 more
wiley +1 more source

